Chinese medicine for treating coronary heart disease

The invention belongs to the field of Chinese medicines, and in particular relates to a Chinese medicine for treating coronary heart disease. The Chinese medicine is prepared from the following raw materials in parts by weight: 5-20 parts of astragalus membranaceus, 6-18 parts of ginseng, 7-12 parts of salvia miltiorrhiza, 4-11 parts of safflower, 6-14 parts of cassia twig, 5-16 parts of sandalwood, 6-19 parts of dendrobe, 8-15 parts of rhizoma anemarrhenae, 7-16 parts of endothelium corneum gigeriae galli, 6-17 parts of dried orange peel, 5-14 parts of smoked plum, 4-18 parts of liquorice, 3-14 parts of radix bupleuri, 6-17 parts of curcuma aromatica, 5-17 parts of curcuma zedoary, 2-11 parts of dandelion, 3-18 parts of atractylodis macrocephalae, 6-14 parts of poria cocos, 5-13 parts of szechwan Chinaberry fruit, 4-17 parts of fructus evodiae, 6-18 parts of concha arcae, 8-14 parts of unprepared rehmannia root, 6-17 parts of the fruit of Chinese wolfberry, 7-15 parts of angelica sinensis, 6-18 parts of radi